Diffuse gliomas with high expression of COL1A2, SAMD9, and KDR had poor prognoses in the CGGA cohort (Figure 2H-J) (log-rank test, P < 0.05), which was consistent with the TCGA cohort. The gene discussed is COL1A2; the disease is glioma.